110 results on '"Schnitzler, M"'
Search Results
2. Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation
3. OPTN/SRTR 2016 Annual Data Report: Economics
4. The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis
5. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation
6. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis
7. OPTN/SRTR 2015 Annual Data Report: Economics
8. Perioperative Complications After Living Kidney Donation: A National Study
9. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients
10. Economics
11. OPTN/SRTR 2013 Annual Data Report: Economics
12. Quantifying Prognostic Impact of Prescription Narcotics Use Before Kidney Transplantation through Linked Registry and Pharmaceutical Claims Data.: Abstract# D2446
13. Differential Risks For 3-Year Adverse Outcomes After Kidney Transplant Based On Initial Immunosuppression and Incorporating Claims Data Records: A National Study.: Abstract# D2429
14. Costs of Pediatric Kidney Transplant.: Abstract# A362
15. Incremental Cost-Effectiveness of Lung Transplant By Lung Allocation Score.: Abstract# 1386
16. Early Hospital Readmissions After Liver Transplantation.: Abstract# 2265
17. Variation in the Incidence Biliary Complications in Liver Transplantation: Outcome and Economic Implications.: Abstract# 2268
18. Racial Variation in the Use of Antihypertensive Medications After Living Kidney Donation.: Abstract# 1382
19. International Comparison of the Cost-Effectiveness of VADS as Bridge to Transplant.: Abstract# 628
20. OPTN/SRTR 2012 Annual Data Report: Liver
21. OPTN/SRTR 2012 Annual Data Report: Heart
22. OPTN/SRTR 2012 Annual Data Report: Kidney
23. OPTN/SRTR 2012 Annual Data Report: Pancreas
24. OPTN/SRTR 2012 Annual Data Report: Lung
25. The Economic Impact of the Utilization of Liver Allografts with High Donor Risk Index
26. Addressing Geographic Disparities in Liver Transplantation Through Redistricting
27. Call to Develop a Standard Acquisition Charge Model for Kidney Paired Donation
28. Potential Use of Pre-Transplant Medications as SRTR Risk Adjusters: The Example of Plavix.: Abstract# 1696: Poster Board #-Session: P258-IV
29. Novel Approaches to Pharmacoepidemiology among Kidney Transplant Recipients: Use of Linked Registry and Claims Data To Examine Medical Care According to eGFR Level.: Abstract# 1688: Poster Board #-Session: P250-IV
30. Modeled Long Term Projections of Clinical Outcomes from BENEFIT and BENEFIT-EXT.: Abstract# 1292: Poster Board #-Session: P159-III
31. Accountability in Transplant Care: Mortality Effect of Decreased Access to Transplantation.: Abstract# 340
32. High Pre-Transplant Insulin Requirements Correlates with Pancreas Failure Risk in SPK.: Abstract# 298
33. Pre-Operative Factors Predict Post-Operative Need for Mechanical Ventilator Support Following Kidney Transplantation: Logistic Regression Model.: Abstract# 115
34. Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
35. MELD Exceptions and Rates of Waiting List Outcomes
36. The Economic Implications of Broader Sharing of Liver Allografts
37. A Risk Prediction Model for Delayed Graft Function in the Current Era of Deceased Donor Renal Transplantation
38. Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression
39. Maintenance Steroid Therapy for Kidney Recipients—Not Ready for Relegation
40. The Cost and Quality Paradox
41. Predictive Ability of Pretransplant Comorbidities to Predict Long-Term Graft Loss and Death
42. Income-Related Disparities in Kidney Transplant Graft Failures Are Eliminated by Medicareʼs Immunosuppression Coverage
43. Association of Lower Costs of Pulsatile Machine Perfusion in Renal Transplantation from Expanded Criteria Donors
44. The Promise and Pitfalls of Transplant Centers
45. Monozygotic Transplantation: Concerns and Opportunities
46. A Retrospective Analysis of Immunosuppression Compliance, Dose Reduction and Discontinuation in Kidney Transplant Recipients
47. Patient and Graft Survival Implications of Simultaneous Pancreas Kidney Transplantation From Old Donors
48. Lack of Interventional Studies in Renal Transplant Candidates with Elevated Cardiovascular Risk
49. Nontransplantation of Livers from Deceased Donors Who Are Able to Donate Another Solid Organ: How Often and Why It Happens
50. Limiting Financial Disincentives in Live Organ Donation: A Rational Solution to the Kidney Shortage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.